Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women

被引:85
|
作者
Janand-Delenne, B
Chagnaud, C
Raccah, D
Alessi, MC
Juhan-Vague, I
Vague, P
机构
[1] Hop Univ Timone, Serv Nutr Endocrinol Malad Metab, Marseille, France
[2] Hop Univ Timone, Serv Radiol, Marseille, France
[3] Hop Univ Timone, Hematol Lab, Marseille, France
关键词
visceral fat; plasminogen activator inhibitor 1 (PAI-1); weight loss;
D O I
10.1038/sj.ijo.0800585
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To substantiate in a premenopausal population of women, the link between visceral adipose tissue and circulating plasminogen activator inhibitor 1 (PAI-1) levels. DESIGN: Study of correlations between anthropometric parameters and PAI-1 and evaluation of the changes induced by weight loss. SUBJECTS: Forty-two healthy pre-menopausal women (aged 18-51 y, with a wide range of body mass index (BMI, 21-48.8 kg/m(2)). Thirteen women were evaluated after weight loss (6.6 +/- 3.3 kg). MEASUREMENTS: BMI, waist and hip circumferences. Total, subcutaneous and visceral adipose tissue areas at the L3-L4 level by computed tomography. Insulin, cholesterol, triglyceride, HDL cholesterol, PAI-1 activity, PAI-1 antigen and tissue plasminogen activator (tPA) antigen. RESULTS: PAI-1 activity, PAI antigen and tPA antigen were positively correlated with visceral adipose tissue, but not with subcutaneous adipose tissue. This correlation was independent of insulin or triglyceride levels. The amount of visceral adipose tissue explained 28% of the PAI-1 activity variance. Weight loss confirmed this link, PAI-1 diminution being correlated only with visceral adipose tissue loss and not with total fat, insulin or triglyceride decrease. CONCLUSION: This study suggests, like in vitro studies, that visceral fat may be an important contributor to the circulating PAI-1.
引用
收藏
页码:312 / 317
页数:6
相关论文
共 32 条
  • [1] Visceral fat as a main determinant of plasminogen activator inhibitor 1 level in women
    B Janand-Delenne
    C Chagnaud
    D Raccah
    MC Alessi
    I Juhan-Vague
    P Vague
    International Journal of Obesity, 1998, 22 : 312 - 317
  • [2] Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat - Evidence of differences between visceral and subcutaneous deposits
    Bastelica, D
    Morange, P
    Berthet, B
    Borghi, H
    Lacroix, O
    Grino, M
    Juhan-Vague, I
    Alessi, MC
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2002, 22 (01) : 173 - 178
  • [3] Human visceral adipose tissue and the plasminogen activator inhibitor type 1
    Lindeman, J. H. N.
    Pijl, H.
    Toet, K.
    Eilers, P. H. C.
    van Ramshorst, B.
    Buijs, M. M.
    van Bockel, J. H.
    Kooistra, T.
    INTERNATIONAL JOURNAL OF OBESITY, 2007, 31 (11) : 1671 - 1679
  • [4] Human visceral adipose tissue and the plasminogen activator inhibitor type 1
    J H N Lindeman
    H Pijl
    K Toet
    P H C Eilers
    B van Ramshorst
    M M Buijs
    J H van Bockel
    T Kooistra
    International Journal of Obesity, 2007, 31 : 1671 - 1679
  • [5] Plasminogen activator inhibitor 1 and visceral obesity during pronounced weight loss after bariatric surgery
    Tschoner, A.
    Sturm, W.
    Engl, J.
    Kaser, S.
    Laimer, M.
    Laimer, E.
    Klaus, A.
    Patsch, J. R.
    Ebenbichler, C. F.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2012, 22 (04) : 340 - 346
  • [6] Visceral Fat Is a Negative Determinant of Bone Health in Obese Postmenopausal Women
    Sharma, Deepti K.
    Anderson, Paul H.
    Morris, Howard A.
    Clifton, Peter M.
    INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2020, 17 (11)
  • [7] Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome
    Koiou, Ekaterini
    Tziomalos, Konstantinos
    Katsikis, Ilias
    Delkos, Dimitrios
    Tsourdi, Elena A.
    Panidis, Dimitrios
    HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2013, 12 (04): : 559 - 566
  • [8] Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome
    Ekaterini Koiou
    Konstantinos Tziomalos
    Ilias Katsikis
    Dimitrios Delkos
    Elena A. Tsourdi
    Dimitrios Panidis
    Hormones, 2013, 12 : 559 - 566
  • [9] The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
    You-Cheol Hwang
    Won Seon Jeon
    Cheol-Young Park
    Byung-Soo Youn
    Cardiovascular Diabetology, 15
  • [10] The ratio of skeletal muscle mass to visceral fat area is a main determinant linking circulating irisin to metabolic phenotype
    Hwang, You-Cheol
    Jeon, Won Seon
    Park, Cheol-Young
    Youn, Byung-Soo
    CARDIOVASCULAR DIABETOLOGY, 2016, 15